Shattuck Labs, Inc

Shattuck Labs, Inc is a biotechnology company based in Austin, TX that specializes in pioneering novel bi-functional fusion proteins. Through their Agonist Redirected Checkpoint (ARC) technology, they have developed a new class of fusion proteins that target and unlock the TNFr superfamily while simultaneously blocking an immune checkpoint, expanding the boundaries of biologic medicines.

With a robust drug pipeline of over 400 bi-functional fusion proteins, Shattuck Labs aims to address multiple areas of high unmet need by targeting clinically validated as well as emerging pathways. Their modular technology allows for efficient creation of thousands of therapeutics, positioning their therapies to pursue both best-in-class and first-in-class approaches.

Generated from the website